集中化对腹主动脉瘤修复结局的影响:加泰罗尼亚早期经验
该研究基于西班牙加泰罗尼亚国家登记数据,分析将腹主动脉瘤(AAA)修复集中至高容量中心(年手术量>30例)前后的短期结局。结果显示集中化后完整AAA修复死亡率从4.7%降至2.0%,破裂AAA从53.1%降至41.9%,住院时间亦显著缩短,支持AAA修复集中化的获益。
要点
- 集中化后完整AAA修复短期死亡率显著下降(4.7% vs 2.0%,p<.001)。
- 开放修复死亡率下降显著(8.7% vs 3.6%,p=.005),EVAR未达显著。
- 破裂AAA死亡率亦下降(53.1% vs 41.9%,p=.028)。
核心结论
- 基于国家的AAA治疗集中化方案显著降低了完整和破裂AAA修复的短期死亡率,且主要见于择期开放修复。
- 集中化后住院时间也显著缩短,主要见于择期EVAR。
- 结果支持AAA修复手术集中化的获益。
研究设计与样本
- 回顾性队列研究,数据来自国家官方登记(HDMBD),覆盖九年期间AAA的EVAR或开放修复。
- 比较集中化前(2009-2014)与完全集中化后(2015-2017)两个时期,集中化定义为高容量中心年手术量>30例。
- 主要目标为确定集中化前后完整和破裂AAA修复的短期死亡率(院内和30天)及住院时间,并进行单因素和多因素分析识别独立预测因素。
主要发现
- 集中化后完整AAA修复总体死亡率显著下降(4.7% vs 2.0%,p<.001)。
- 破裂AAA修复总体死亡率显著下降(53.1% vs 41.9%,p=.028)。
- 完整AAA中开放修复死亡率下降显著(8.7% vs 3.6%,p=.005),EVAR未达显著(2.2% vs 1.5%,p=.25)。
- 总体住院时间缩短,主要见于完整AAA(9.49±10.84 vs 7.44±12.23天,p<.001),尤其择期EVAR(7.32±7.73 vs 6.00±8.97天,p<.001)。
- 多因素分析显示集中化前时期是死亡率的独立预测因素(OR 1.484,95%CI 1.098-2.005,p=.010)和住院时间的独立预测因素(B系数1.146,95%CI 0.218-2.073,p=.016)。
临床怎么用
- 对于腹主动脉瘤修复,可考虑将手术集中至年手术量>30例的高容量中心以改善短期结局。
- 集中化策略对择期开放修复的死亡率改善尤为明显,对EVAR的死亡率改善不显著。
- 集中化可能缩短完整AAA修复尤其是择期EVAR的住院时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Several studies have revealed high volume centres have better outcomes in the treatment of abdominal aortic aneurysms (AAAs), thus supporting centralisation of this procedure into selected centres based on volume. To date however, the real benefit of centralisation of this pathology has not been well demonstrated. The aim of this study was to analyse the impact of centralisation in to high volume centres (defined as those performing more than 30 cases per year) on AAA treatment outcomes carried out in Catalonia (Spain). METHODS: Data were collected from official national registries (HDMBD) for AAA treated by endovascular aneurysm repair (EVAR) or open repair (OR) over a nine year period. Two time periods were selected for comparison: before centralisation (2009-2014) and after complete centralisation (2015-2017). The primary objective was to determine short term mortality (in hospital and 30 day mortality) and length of stay (LOS) after intact AAA (iAAA) and ruptured AAA (rAAA) repair, before and after centralisation. Uni- and multivariable analyses were performed in order to identify independent outcomes predictors. RESULTS: A total of 3 501 iAAAs, including 1 124 (32.1%) OR and 2377 (67.9%) EVAR, and 409 rAAAs, including 218 (53.3%) OR and 191 (46.7%) EVAR, were identified. After centralisation, there was a significant decrease in overall mortality in iAAA repair (4.7% vs. 2.0%, p < .001) and rAAA repair (53.1% vs. 41.9%, p = .028). Mortality reduction in iAAAs was significant for OR (8.7% vs. 3.6%, p = .005), but not for EVAR (2.2% vs. 1.5%, p = .25). Overall LOS decreased as well, mainly in iAAAs (9.49 ± 10.84 vs. 7.44 ± 12.23 days, p < .001), and in particular in elective EVAR (7.32 ± 7.73 vs. 6.00 ± 8.97 days, p < .001). Multivariable analysis was identified before the centralisation period as an independent predictor for both mortality (odds ratio 1.484, 95% CI 1.098-2.005, p = .010) and LOS (B coefficient 1.146, 95% CI 0.218-2.073, p = .016). CONCLUSION: The implementation of a country based centralisation programme for AAA treatment led to a significant reduction in short term mortality, for both iAAA and rAAA, and mainly for elective OR. LOS also significantly decreased, mainly for elective EVAR. These results support the benefit of centralisation of AAA repair procedures.
引用
- Tripodi P, Mestres G, Riambau V, et al. Impact of Centralisation on Abdominal Aortic Aneurysm Repair Outcomes: Early Experience in Catalonia. Eur J Vasc Endovasc Surg. 2020. PMID: 32312668. doi:10.1016/j.ejvs.2020.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。